Overview
Modifier 25 is appended to an evaluation and management (E&M) code when the same clinician performs a significant, separately identifiable E&M service on the same calendar date as a procedure with a global period. Without the modifier, payers bundle the E&M into the procedure's global surgical package and pay only the procedure. With the modifier — and properly supported documentation — both services are eligible for separate payment.
The clinical scenarios that justify modifier 25 are well-defined. A patient presents for a scheduled procedure (joint injection, laceration repair, skin lesion removal) but also has a separate complaint warranting evaluation and management — for example, an injection patient who also reports new chest pain. The E&M portion, if sufficiently documented and distinct from the pre-service evaluation inherent to the procedure, is separately reportable with modifier 25. The modifier does not require a new or unrelated diagnosis; the E&M may address the same condition as the procedure, provided the documented work exceeds the procedure's routine pre- and post-service evaluation.
Payer scrutiny is intense. Modifier 25 is one of the most audited modifiers in the CPT set because it is both commonly used and frequently misapplied. The OIG Work Plan has repeatedly targeted modifier 25 billing patterns. Medicare Administrative Contractors and commercial payer Special Investigations Units run claims-data analytics that flag providers with unusually high modifier-25 rates relative to specialty norms. Individual claim-level scrutiny focuses on whether the documentation establishes the E&M as both (1) significant and (2) separately identifiable from the procedure. Vague notes that do not clearly separate the E&M work from procedure pre-service evaluation are denied or recouped on audit.
Payer rules layer on top of CPT guidance. Many commercial payers — Anthem, Cigna, UnitedHealthcare among others — have implemented policies that reduce payment on E&M codes billed with modifier 25 by 25 percent or 50 percent on the theory that overlapping evaluation work is inherent. AMA and specialty-society advocacy has slowed or reversed some of these policies, but partial payment reduction remains a common payer behavior. Reading each payer's modifier-25 reimbursement policy — not just the CPT guidelines — is operationally necessary.
Compliant modifier-25 use requires three elements in the documentation: a clear statement of the additional clinical problem addressed, distinct history and examination documentation for the E&M beyond the procedure's pre-service evaluation, and medical decision-making that supports the E&M level billed. Coders and auditors look for the separation in the note — ideally organized so the E&M and procedure work are documented in distinct sections. When the separation is unclear, the safer posture is to bill the procedure alone rather than defend an audit on ambiguous documentation.
Industry benchmark
The OIG Work Plan has repeatedly targeted modifier 25 usage; CMS, MACs, and commercial payer SIUs run active audit programs on modifier-25 claims. Multiple major payers have implemented modifier-25 reimbursement reductions of 25–50%, some rolled back under AMA and specialty-society advocacy. Read each payer's current modifier-25 reimbursement policy — it changes annually.
Worked example
A patient presents for a planned knee injection (procedure) and during the visit reports new-onset shortness of breath. The clinician performs a separately documented cardiopulmonary history, examination, and workup, and proceeds with the injection. The claim submits the injection code with the applicable E&M code and modifier 25. The documentation clearly separates the E&M work from the injection pre-service evaluation. The payer processes both services as separately payable.
Frequently asked questions — Modifier 25
When is modifier 25 appropriate?
When a significant, separately identifiable E&M service is performed on the same day as a procedure with a global period, and the documentation clearly separates the E&M work from the procedure's inherent pre- and post-service evaluation. The E&M may or may not relate to the procedure's diagnosis; what matters is that the work is distinct and documented.
Do payers reduce payment on modifier 25 claims?
Several major commercial payers have implemented reimbursement reductions of 25–50% on E&M codes billed with modifier 25. Some programs have been rolled back under AMA and specialty-society advocacy. Each payer's current policy should be read annually — the landscape changes.
Why is modifier 25 so heavily audited?
Because it is commonly used, permits separate payment for what might otherwise be bundled, and is sometimes applied where the documentation does not clearly establish the E&M as significant and separately identifiable. OIG, MACs, RACs, and commercial SIUs run claims-data analytics that flag outlier billing patterns.
How should modifier 25 documentation be structured?
Best practice is to document the E&M and the procedure in clearly separated sections of the note, with the E&M portion containing its own history, examination, and medical decision-making that exceed the procedure's pre-service evaluation. Ambiguous combined notes are the most common cause of modifier-25 audit findings.
Disclaimer
This glossary entry is operational reference for revenue-cycle and medical-billing professionals. It is not legal, clinical, or contractual advice. Industry benchmarks cite named public sources where available; always verify against the current guidance from the authority body before relying on a number in a contract, policy, or compliance filing.